SLC7A3 and invasive ductal breast carcinoma: The cBioPortal database analysis revealed that approximately 80% of breast invasive ductal carcinoma patients have low SLC7A3 mRNA expression levels, suggesting that reduced SLC7A3 gene transcription may contribute to poor prognosis in this subset of patients.